植物由来医薬品市場：タイプ別、供給源別、治療用途別、製剤別、エンドユーザー別、投与経路別-2025-2030年世界予測

植物由来医薬品市場は、2023年に37億5,000万米ドルと評価され、2024年には40億1,000万米ドルに達すると予測され、CAGR 6.96％で成長し、2030年には60億1,000万米ドルに達すると予測されています。

植物由来の複雑な混合物として定義される植物医薬品は、その天然由来と治療の可能性により人気を集めています。これらの医薬品は、チンキ剤、お茶、エッセンシャルオイルなど様々な形態を含み、特に薬効を持つ抽出物の標準化に重点を置いています。植物性医薬品の必要性は、自然で持続可能なヘルスケアの選択肢に対する消費者の嗜好の高まりと、世界の規制機関による受け入れの拡大に起因しています。植物性医薬品は主に、関節炎、心血管系疾患、がんなど、従来の治療法では困難であったり副作用が大きかったりする慢性疾患の治療に応用されています。最終用途の範囲には、医薬品、栄養補助食品、パーソナルケア産業が含まれ、伝統医療とホリスティック・ヘルスへの関心の高まりから恩恵を受けています。市場の洞察によると、主な成長要因としては、研究開発投資の活発化、有利な規制、植物由来の健康ソリューションに対する一般の意識の高まりなどが挙げられます。最新のビジネスチャンスは、植物療法の個別化と統合医療への応用拡大です。こうした機会を生かすための調査には、研究のための戦略的パートナーシップの育成、持続可能な調達のためのサプライチェーンの最適化、公衆衛生教育への関与などが含まれます。しかし、規制の枠組みが複雑であること、合成物質に比べ臨床データが限られていること、自然の変動による製品の一貫性の維持が課題であることなど、限界もあります。さらに、サプライチェーンの混乱や厳しい特許法が市場成長の妨げになる可能性もあります。技術革新のための最良の分野としては、抽出方法の改善、標準化された製剤の開発、バイオテクノロジーの進歩を活用して植物医薬品の治療効果と安全性プロファイルを高めることなどが挙げられます。市場は多数の中小企業によって細分化されているため、的を絞ったイノベーションと機敏な事業戦略によってニッチ・リーダーシップを確立する機会が豊富にあります。消費者の動向を理解し、拡張可能なインフラに投資することは、植物医薬品の複雑な情勢を乗り切る上で極めて重要であり、一方で、進化する規制状況に遅れをとらないことは競争力を高めることにつながります。

市場力学：急速に進化する植物由来医薬品市場の主要市場インサイトを公開

植物由来医薬品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 植物医薬品の開発を支援する政府の取り組みと資金援助
  • 植物製品の流通チャネルとeコマース・プラットフォームの拡大
  • 植物由来医薬品製造における高度な抽出・製剤技術の採用
  • 主要市場企業による植物由来医薬品研究と商業化への多額の投資
• 市場抑制要因
  • 植物医薬品の有効性と安全性に関する限られた臨床試験データと科学的検証
  • 知的財産の課題と合成医薬品との競合が市場成長を阻害する
• 市場機会
  • 慢性疾患の有病率の増加により、代替治療のための植物医薬品の採用が増加
  • eコマース・プラットフォームを含む流通チャネルの拡大による市場へのリーチとアクセシビリティの向上
  • 個人の健康ニーズや嗜好に対応する個別化植物薬の市場開拓が市場成長を促進
• 市場の課題
  • 植物由来医薬品の有効性と安全性の主張を裏付ける科学的根拠と臨床試験が限られていることが市場の成長を妨げる
  • サプライチェーンの混乱と原料不足が植物由来医薬品業界の生産一貫性に影響

ポーターの5つの力：植物由来医薬品市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、植物由来医薬品市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：植物由来医薬品市場における外部からの影響の把握

外部マクロ環境要因は、植物由来医薬品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析植物由来医薬品市場における競合情勢の把握

植物由来医薬品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス植物由来医薬品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、植物由来医薬品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨植物由来医薬品市場における成功への道筋を描く

植物由来医薬品市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 植物薬の開発を支援する政府の取り組みと資金
    • 植物由来製品の流通チャネルとeコマースプラットフォームの拡大
    • 植物由来医薬品製造における高度な抽出・配合技術の採用
    • 主要な市場プレーヤーによる植物由来医薬品の調査と商業化への多額の投資
  • 抑制要因
    • 植物薬の有効性と安全性に関する臨床試験データと科学的検証は限られている
    • 知的財産権の課題と合成薬との競合が市場の成長を阻害
  • 機会
    • 慢性疾患の罹患率の上昇により、代替治療のための植物薬の採用が増加
    • eコマースプラットフォームを含む流通チャネルの拡大により、市場へのリーチとアクセス性が向上
    • 個人の健康ニーズや嗜好に合わせたパーソナライズされた植物薬の開発が市場の成長を牽引
  • 課題
    • 有効性と安全性の主張を裏付ける科学的証拠と臨床試験が限られているため、市場の成長が妨げられている
    • サプライチェーンの混乱と原材料不足が植物由来医薬品業界の生産の一貫性に影響を与える
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTLE分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 植物由来医薬品市場：タイプ別

• ハーブ薬
  • 複数のハーブ薬
  • 単一ハーブ薬
• 栄養補助食品
• 植物薬

第7章 植物由来医薬品市場：ソース別

• 藻類
• 菌類
• 植物
  • 吠える
  • 葉
  • ルーツ
  • 種子

第8章 植物由来医薬品市場治療用途別

• がん
• 心血管疾患
• 糖尿病
• 消化器疾患
• 呼吸器疾患

第9章 植物由来医薬品市場処方別

• カプセル
• 抜粋
• 軟膏
• 粉末
• タブレット

第10章 植物由来医薬品市場：エンドユーザー別

• クリニック
• ホームケア
• 病院

第11章 植物由来医薬品市場：投与経路別

• 注射可能
• オーラル
• 話題

第12章 南北アメリカの植物由来医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の植物由来医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの植物由来医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Aphios Corporation
• 2. Botanix Pharmaceuticals Ltd
• 3. CanniMed Therapeutics Inc.
• 4. Cardiol Therapeutics Inc.
• 5. CV Sciences, Inc.
• 6. Ecofibre Limited
• 7. EcoGen Laboratories
• 8. Emerald Health Pharmaceuticals
• 9. GB Sciences, Inc.
• 10. GW Pharmaceuticals plc
• 11. HempMeds
• 12. InMed Pharmaceuticals Inc.
• 13. Jazz Pharmaceuticals plc
• 14. Lexaria Bioscience Corp.
• 15. MediPharm Labs Corp.
• 16. PhytoTech Therapeutics Ltd.
• 17. Tetra Bio-Pharma Inc.
• 18. Tikun Olam Ltd.
• 19. Veritas Pharma Inc.
• 20. Zynerba Pharmaceuticals, Inc.

LIST OF FIGURES

• FIGURE 1. BOTANICAL DRUG MARKET RESEARCH PROCESS
• FIGURE 2. BOTANICAL DRUG MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BOTANICAL DRUG MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BOTANICAL DRUG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 21. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. BOTANICAL DRUG MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 27. BOTANICAL DRUG MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BOTANICAL DRUG MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BOTANICAL DRUG MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BOTANICAL DRUG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BOTANICAL DRUG MARKET DYNAMICS
• TABLE 7. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BOTANICAL DRUG MARKET SIZE, BY MULTIPLE HERB DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SINGLE HERB DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BOTANICAL DRUG MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PHYTOMEDICINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FUNGI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BOTANICAL DRUG MARKET SIZE, BY BARKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BOTANICAL DRUG MARKET SIZE, BY LEAVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROOTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BOTANICAL DRUG MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BOTANICAL DRUG MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BOTANICAL DRUG MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BOTANICAL DRUG MARKET SIZE, BY EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BOTANICAL DRUG MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BOTANICAL DRUG MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL BOTANICAL DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 58. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. BRAZIL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 66. BRAZIL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 68. CANADA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. CANADA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 70. CANADA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 71. CANADA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 72. CANADA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. CANADA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 74. CANADA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. CANADA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 78. MEXICO BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 79. MEXICO BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 80. MEXICO BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. MEXICO BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 82. MEXICO BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 87. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 88. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 90. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 95. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 96. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 97. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 99. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 102. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 104. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 105. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 106. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 108. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 110. CHINA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. CHINA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 112. CHINA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 113. CHINA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 114. CHINA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. CHINA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 116. CHINA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. CHINA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 118. INDIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. INDIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 120. INDIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 121. INDIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 122. INDIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. INDIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 124. INDIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. INDIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 126. INDONESIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. INDONESIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 128. INDONESIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 129. INDONESIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 130. INDONESIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. INDONESIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 132. INDONESIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. INDONESIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 134. JAPAN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. JAPAN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 136. JAPAN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 137. JAPAN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 138. JAPAN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. JAPAN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 140. JAPAN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. JAPAN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 142. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 144. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 145. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 146. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 148. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 150. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 152. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 153. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 154. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 156. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 158. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 160. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 161. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 162. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 164. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 165. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 174. TAIWAN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. TAIWAN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 176. TAIWAN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 177. TAIWAN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 178. TAIWAN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. TAIWAN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 180. TAIWAN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. TAIWAN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 182. THAILAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. THAILAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 184. THAILAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 185. THAILAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 186. THAILAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. THAILAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 188. THAILAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. THAILAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 190. VIETNAM BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. VIETNAM BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 192. VIETNAM BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 193. VIETNAM BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 194. VIETNAM BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. VIETNAM BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 196. VIETNAM BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. VIETNAM BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 207. DENMARK BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 208. DENMARK BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 209. DENMARK BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 210. DENMARK BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 211. DENMARK BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. DENMARK BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 213. DENMARK BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 214. DENMARK BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 215. EGYPT BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 216. EGYPT BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 217. EGYPT BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 218. EGYPT BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 219. EGYPT BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. EGYPT BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 221. EGYPT BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. EGYPT BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 223. FINLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 224. FINLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 225. FINLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 226. FINLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 227. FINLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. FINLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 229. FINLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 230. FINLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 231. FRANCE BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. FRANCE BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 233. FRANCE BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 234. FRANCE BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 235. FRANCE BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. FRANCE BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 237. FRANCE BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. FRANCE BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 239. GERMANY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 240. GERMANY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 241. GERMANY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 242. GERMANY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 243. GERMANY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. GERMANY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 245. GERMANY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 246. GERMANY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 247. ISRAEL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 248. ISRAEL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 249. ISRAEL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 250. ISRAEL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 251. ISRAEL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 252. ISRAEL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 253. ISRAEL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 254. ISRAEL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 255. ITALY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 256. ITALY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 257. ITALY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 258. ITALY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 259. ITALY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 260. ITALY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 261. ITALY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 262. ITALY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 263. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 264. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 265. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 266. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 267. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 269. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 270. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 271. NIGERIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 272. NIGERIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 273. NIGERIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 274. NIGERIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 275. NIGERIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 276. NIGERIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 277. NIGERIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 278. NIGERIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 279. NORWAY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 280. NORWAY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 281. NORWAY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 282. NORWAY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 283. NORWAY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 284. NORWAY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 285. NORWAY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 286. NORWAY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 287. POLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 288. POLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 289. POLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 290. POLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 291. POLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 292. POLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 293. POLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 294. POLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 295. QATAR BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 296. QATAR BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 297. QATAR BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 298. QATAR BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 299. QATAR BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 300. QATAR BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 301. QATAR BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 302. QATAR BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 303. RUSSIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 304. RUSSIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 305. RUSSIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 306. RUSSIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 307. RUSSIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 308. RUSSIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 309. RUSSIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 310. RUSSIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 311. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 312. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 313. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 314. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 315. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 316. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 317. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 318. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 319. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 320. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 321. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 322. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 323. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 324. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 325. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 326. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 327. SPAIN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 328. SPAIN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 329. SPAIN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 330. SPAIN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 331. SPAIN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 332. SPAIN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 333. SPAIN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 334. SPAIN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 335. SWEDEN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 336. SWEDEN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 337. SWEDEN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 338. SWEDEN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 339. SWEDEN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 340. SWEDEN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 341. SWEDEN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 342. SWEDEN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 343. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 344. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 345. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 346. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 347. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 348. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 349. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 350. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 351. TURKEY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 352. TURKEY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 353. TURKEY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 354. TURKEY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 355. TURKEY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 356. TURKEY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 357. TURKEY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 358. TURKEY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 359. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 360. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 361. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 362. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
• TABLE 363. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 364. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 365. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 366. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 367. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 368. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
• TABLE 369. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY SOURCE, 201

The Botanical Drug Market was valued at USD 3.75 billion in 2023, expected to reach USD 4.01 billion in 2024, and is projected to grow at a CAGR of 6.96%, to USD 6.01 billion by 2030.

Botanical drugs, defined as complex mixtures derived from plant-based sources, have been gaining traction due to their natural origin and therapeutic potential. These drugs encompass various forms, including tinctures, teas, and essential oils, focusing especially on standardizing extracts with medicinal properties. The necessity for botanical drugs stems from the rising consumer preference for natural, sustainable healthcare options coupled with increased acceptance by global regulatory bodies. They are primarily applied in treating chronic diseases, such as arthritis, cardiovascular ailments, and cancer, where conventional treatments may falter or present significant side effects. The scope of end-use includes pharmaceutical, nutraceutical, and personal care industries, benefitting from growing interests in traditional medicine and holistic health. Market insights reveal that key growth factors include heightened R&D investments, favorable regulations, and increased public awareness of plant-based health solutions. Latest opportunities lie in personalizing botanical therapies and expanding applications in integrative medicine practices. Recommendations to capitalize on these opportunities include fostering strategic partnerships for research, optimizing supply chains for sustainable sourcing, and engaging in public health education. However, limitations include complex regulatory frameworks, limited clinical data compared to synthetics, and challenges in maintaining product consistency due to natural variability. Additionally, supply chain disruptions and stringent patent laws can hinder market growth. The best areas for innovation involve improving extraction methods, developing standardized formulations, and leveraging biotechnological advancements to enhance therapeutic efficacy and safety profiles of botanical drugs. As the market is characterized by fragmentation with numerous small to mid-sized firms, opportunities abound for establishing niche leadership through targeted innovations and agile business strategies. Understanding consumer trends and investing in a scalable infrastructure is crucial for navigating the complex landscape of botanical drugs, while staying abreast of evolving regulatory standards can provide a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Botanical Drug Market

The Botanical Drug Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Government initiatives and funding supporting the development of botanical drugs
  • Expansion of distribution channels and e-commerce platforms for botanical products
  • Adoption of advanced extraction and formulation technologies in botanical drug manufacturing
  • Significant investments by key market players in botanical drug research and commercialization
• Market Restraints
  • Limited clinical trial data and scientific validation on the efficacy and safety of botanical drugs
  • Intellectual property challenges and competition with synthetic drugs impede market growth
• Market Opportunities
  • Rising prevalence of chronic diseases increasing the adoption of botanical drugs for alternative treatment
  • Expansion of distribution channels including e-commerce platforms boosting market reach and accessibility
  • Development of personalized botanical medicine catering to individual health needs and preferences driving market growth
• Market Challenges
  • Limited scientific evidence and clinical trials to support botanical drug efficacy and safety claims hamper market growth
  • Supply chain disruptions and raw material scarcity affect production consistency in the botanical drug industry

Porter's Five Forces: A Strategic Tool for Navigating the Botanical Drug Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Botanical Drug Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Botanical Drug Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Botanical Drug Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Botanical Drug Market

A detailed market share analysis in the Botanical Drug Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Botanical Drug Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Botanical Drug Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Botanical Drug Market

A strategic analysis of the Botanical Drug Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Botanical Drug Market, highlighting leading vendors and their innovative profiles. These include Aphios Corporation, Botanix Pharmaceuticals Ltd, CanniMed Therapeutics Inc., Cardiol Therapeutics Inc., CV Sciences, Inc., Ecofibre Limited, EcoGen Laboratories, Emerald Health Pharmaceuticals, GB Sciences, Inc., GW Pharmaceuticals plc, HempMeds, InMed Pharmaceuticals Inc., Jazz Pharmaceuticals plc, Lexaria Bioscience Corp., MediPharm Labs Corp., PhytoTech Therapeutics Ltd., Tetra Bio-Pharma Inc., Tikun Olam Ltd., Veritas Pharma Inc., and Zynerba Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Botanical Drug Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Herbal Drugs, Nutraceuticals, and Phytomedicines. The Herbal Drugs is further studied across Multiple Herb Drugs and Single Herb Drugs.
• Based on Source, market is studied across Algae, Fungi, and Plants. The Plants is further studied across Barks, Leaves, Roots, and Seeds.
• Based on Therapeutic Application, market is studied across Cancer, Cardiovascular Diseases, Diabetes, Digestive Disorders, and Respiratory Disorders.
• Based on Formulation, market is studied across Capsules, Extracts, Ointments, Powders, and Tablets.
• Based on End User, market is studied across Clinics, Homecare, and Hospitals.
• Based on Route Of Administration, market is studied across Injectable, Oral, and Topical.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Government initiatives and funding supporting the development of botanical drugs
    • 5.1.1.2. Expansion of distribution channels and e-commerce platforms for botanical products
    • 5.1.1.3. Adoption of advanced extraction and formulation technologies in botanical drug manufacturing
    • 5.1.1.4. Significant investments by key market players in botanical drug research and commercialization
  • 5.1.2. Restraints
    • 5.1.2.1. Limited clinical trial data and scientific validation on the efficacy and safety of botanical drugs
    • 5.1.2.2. Intellectual property challenges and competition with synthetic drugs impede market growth
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising prevalence of chronic diseases increasing the adoption of botanical drugs for alternative treatment
    • 5.1.3.2. Expansion of distribution channels including e-commerce platforms boosting market reach and accessibility
    • 5.1.3.3. Development of personalized botanical medicine catering to individual health needs and preferences driving market growth
  • 5.1.4. Challenges
    • 5.1.4.1. Limited scientific evidence and clinical trials to support botanical drug efficacy and safety claims hamper market growth
    • 5.1.4.2. Supply chain disruptions and raw material scarcity affect production consistency in the botanical drug industry
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Botanical Drug Market, by Type

• 6.1. Introduction
• 6.2. Herbal Drugs
  • 6.2.1. Multiple Herb Drugs
  • 6.2.2. Single Herb Drugs
• 6.3. Nutraceuticals
• 6.4. Phytomedicines

7. Botanical Drug Market, by Source

• 7.1. Introduction
• 7.2. Algae
• 7.3. Fungi
• 7.4. Plants
  • 7.4.1. Barks
  • 7.4.2. Leaves
  • 7.4.3. Roots
  • 7.4.4. Seeds

8. Botanical Drug Market, by Therapeutic Application

• 8.1. Introduction
• 8.2. Cancer
• 8.3. Cardiovascular Diseases
• 8.4. Diabetes
• 8.5. Digestive Disorders
• 8.6. Respiratory Disorders

9. Botanical Drug Market, by Formulation

• 9.1. Introduction
• 9.2. Capsules
• 9.3. Extracts
• 9.4. Ointments
• 9.5. Powders
• 9.6. Tablets

10. Botanical Drug Market, by End User

• 10.1. Introduction
• 10.2. Clinics
• 10.3. Homecare
• 10.4. Hospitals

11. Botanical Drug Market, by Route Of Administration

• 11.1. Introduction
• 11.2. Injectable
• 11.3. Oral
• 11.4. Topical

12. Americas Botanical Drug Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Botanical Drug Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Botanical Drug Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aphios Corporation
• 2. Botanix Pharmaceuticals Ltd
• 3. CanniMed Therapeutics Inc.
• 4. Cardiol Therapeutics Inc.
• 5. CV Sciences, Inc.
• 6. Ecofibre Limited
• 7. EcoGen Laboratories
• 8. Emerald Health Pharmaceuticals
• 9. GB Sciences, Inc.
• 10. GW Pharmaceuticals plc
• 11. HempMeds
• 12. InMed Pharmaceuticals Inc.
• 13. Jazz Pharmaceuticals plc
• 14. Lexaria Bioscience Corp.
• 15. MediPharm Labs Corp.
• 16. PhytoTech Therapeutics Ltd.
• 17. Tetra Bio-Pharma Inc.
• 18. Tikun Olam Ltd.
• 19. Veritas Pharma Inc.
• 20. Zynerba Pharmaceuticals, Inc.